Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

ClinicalTrials.gov ID: NCT00483548

Public ClinicalTrials.gov record NCT00483548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression

Study identification

NCT ID
NCT00483548
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
298 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Ziprasidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Mar 9, 2021

2007 – 2008

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
53
Facility City State ZIP Site status
Pfizer Investigational Site Chandler Arizona 85226
Pfizer Investigational Site Litchfield Park Arizona 85340
Pfizer Investigational Site Little Rock Arkansas 72211
Pfizer Investigational Site Little Rock Arkansas 72223
Pfizer Investigational Site Springdale Arkansas 72762
Pfizer Investigational Site Costa Mesa California 92627
Pfizer Investigational Site Oceanside California 92056
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site Torrance California 90502
Pfizer Investigational Site Boca Raton Florida 33486-1340
Pfizer Investigational Site Boca Raton Florida 33486
Pfizer Investigational Site Jacksonville Florida 32256-2006
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Sanford Florida 32771
Pfizer Investigational Site St. Petersburg Florida 33702
Pfizer Investigational Site West Palm Beach Florida 33407
Pfizer Investigational Site Chicago Illinois 60640
Pfizer Investigational Site Skokie Illinois 60077
Pfizer Investigational Site Greenwood Indiana 46143
Pfizer Investigational Site Indianapolis Indiana 46260
Pfizer Investigational Site Topeka Kansas 66606
Pfizer Investigational Site Wichita Kansas 67207
Pfizer Investigational Site Lake Charles Louisiana 70601
Pfizer Investigational Site Rockville Maryland 20852
Pfizer Investigational Site Boston Massachusetts 02135
Pfizer Investigational Site Watertown Massachusetts 02472
Pfizer Investigational Site Clinton Township Michigan 48038
Pfizer Investigational Site Saint Charles Missouri 63301
Pfizer Investigational Site St Louis Missouri 63044-2588
Pfizer Investigational Site Lincoln Nebraska 68510
Pfizer Investigational Site Nashua New Hampshire 03060
Pfizer Investigational Site Cherry Hill New Jersey 08002
Pfizer Investigational Site Clementon New Jersey 08021
Pfizer Investigational Site Brooklyn New York 11201
Pfizer Investigational Site Glen Oaks New York 11004
Pfizer Investigational Site New York New York 10023
Pfizer Investigational Site Olean New York 14760
Pfizer Investigational Site Rochester New York 14618
Pfizer Investigational Site Staten Island New York 10312
Pfizer Investigational Site Chapel Hill North Carolina 27599
Pfizer Investigational Site Cincinnati Ohio 45227
Pfizer Investigational Site Cincinnati Ohio 45267-0516
Pfizer Investigational Site Columbus Ohio 43210
Pfizer Investigational Site Dayton Ohio 45408
Pfizer Investigational Site Oklahoma City Oklahoma 73116
Pfizer Investigational Site Oklahoma City Oklahoma 73119
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Philadelphia Pennsylvania 19104
Pfizer Investigational Site Philadelphia Pennsylvania 19139
Pfizer Investigational Site Memphis Tennessee 38117
Pfizer Investigational Site Austin Texas 78754
Pfizer Investigational Site Austin Texas 78756
Pfizer Investigational Site Houston Texas 77040
Pfizer Investigational Site Houston Texas 77074
Pfizer Investigational Site Lake Jackson Texas 77566
Pfizer Investigational Site Charlottesville Virginia 22903
Pfizer Investigational Site Kirkland Washington 98033
Pfizer Investigational Site Richland Washington 99352
Pfizer Investigational Site Seattle Washington 98104
Pfizer Investigational Site Brown Deer Wisconsin 53223

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00483548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00483548 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →